CLDX vs EQIX · rev $37.0K vs P/E 79, rev $5.07B
Celldex Therapeutics Inc (CLDX) versus Equinix Inc (EQIX) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
Latest reported EQIX revenue for 2026-06-30 was $5.07B. Net income was $894.0M. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
CLDX currently screens at market cap $2.35B. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Not investment advice. Open the CLDX and EQIX stock pages for the full models.
Not investment advice.